Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Acquisitions & Divestments (2023 - 2025)

Historic Change in Acquisitions & Divestments for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $72.7 million.

  • Upstream Bio's Change in Acquisitions & Divestments fell 323.15% to $72.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $279.6 million, marking a year-over-year increase of 5805.97%. This contributed to the annual value of $231.6 million for FY2024, which is 40037.8% up from last year.
  • According to the latest figures from Q3 2025, Upstream Bio's Change in Acquisitions & Divestments is $72.7 million, which was down 323.15% from $69.9 million recorded in Q2 2025.
  • Over the past 5 years, Upstream Bio's Change in Acquisitions & Divestments peaked at $84.3 million during Q4 2024, and registered a low of $29.6 million during Q4 2023.
  • Its 3-year average for Change in Acquisitions & Divestments is $57.1 million, with a median of $61.3 million in 2025.
  • In the last 5 years, Upstream Bio's Change in Acquisitions & Divestments skyrocketed by 18524.73% in 2024 and then crashed by 323.15% in 2025.
  • Upstream Bio's Change in Acquisitions & Divestments (Quarter) stood at $29.6 million in 2023, then skyrocketed by 185.25% to $84.3 million in 2024, then fell by 13.75% to $72.7 million in 2025.
  • Its last three reported values are $72.7 million in Q3 2025, $69.9 million for Q2 2025, and $52.7 million during Q1 2025.